Literature DB >> 17251878

Adrenal status in children with septic shock using low-dose stimulation test.

Manjunatha Sarthi1, Rakesh Lodha, Subbiah Vivekanandhan, Narendra K Arora.   

Abstract

OBJECTIVES: There is paucity of data on the magnitude of absolute or relative adrenal insufficiency in septic shock, especially in children. We conducted a prospective study to determine the prevalence of adrenal insufficiency in children with septic shock using a low-dose Synacthen (1 microg) stimulation test.
DESIGN: Cross-sectional study.
SETTING: Pediatric intensive care unit in a tertiary care hospital in northern India. PATIENTS: Children with septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We performed cortisol estimation at baseline and after low-dose Synacthen (1 microg) stimulation at 30 and 60 mins in children with fluid refractory septic shock admitted to our pediatric intensive care unit. Basal cortisol levels <7 microg/dL and peak cortisol level <18 microg/dL were used to define adrenal insufficiency. An increment of <9 microg/dL after stimulation was used to diagnose relative adrenal insufficiency. As there is lack of consensus on the cutoffs for defining relative adrenal insufficiency using the low-dose adrenocorticotropic hormone test, we evaluated different cutoff values (increment at 30 mins, increment at 60 mins, greater of the two increments) and evaluated their association with the incidence of catecholamine refractory shock and outcomes. Children with sepsis but without septic shock were sampled for baseline cortisol levels as a comparison. Thirty children (15 girls) with septic shock were included; median age (95% confidence interval) was 36.5 (9.39- 58.45) months. Median Pediatric Risk of Mortality score was 22.5 (14.13-24.87). Fifteen (50%) children survived. The median (95% confidence interval) cortisol values at baseline and 30 mins and 60 mins after stimulation were 71 (48.74-120.23) microg/dL, 78.1 (56.9-138.15) microg/dL, and 91 (56.17-166.44) microg/dL, respectively. The median baseline cortisol value in age- and gender-matched children with sepsis was 11.5 microg/dL. None of the children with septic shock fulfilled the criteria for absolute adrenal insufficiency. However, nine (30%) patients had relative adrenal insufficiency (increment in cortisol <9 microg/dL). Of these nine patients, five (56%) died; of the 21 patients with a greater increment in cortisol after stimulation, ten died (p = .69). Compared with patients in septic shock with normal adrenal reserve, those with relative adrenal insufficiency had a higher incidence of catecholamine refractory shock (p = .019) but no difference in mortality rate (p = .69). On the sensitivity and specificity analysis using various cutoffs of increment, the best discrimination for catecholamine refractory shock was obtained with a peak increment <6 microg/dL.
CONCLUSIONS: Relative adrenal insufficiency is common in children with septic shock and is associated with catecholamine refractory shock.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251878     DOI: 10.1097/01.pcc.0000256622.63135.90

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  20 in total

1.  Steroids in septic shock: the confusion continues.

Authors:  Shane M Tibby
Journal:  Arch Dis Child       Date:  2007-07       Impact factor: 3.791

2.  A prospective multicenter study of adrenal function in critically ill children.

Authors:  Kusum Menon; Roxanne E Ward; Margaret L Lawson; Isabelle Gaboury; James S Hutchison; Paul C Hébert
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

3.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

4.  Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan.

Authors:  Muhammad Rehan Khan; Prem Kumar Maheshwari; Komal Masood; Farah Naz Qamar; Anwar-Ul Haque
Journal:  Indian J Pediatr       Date:  2012-03-06       Impact factor: 1.967

5.  A Single-Center Review of Prescribing Trends and Outcomes of Corticosteroid Replacement Therapy in Critically Ill Children with Septic Shock.

Authors:  Scott T Benken; Tamara K Hutson; Rhonda L Gardiner; Derek S Wheeler
Journal:  Open Crit Care Med J       Date:  2010-01-01

Review 6.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

7.  Pediatric Sepsis Guidelines: Summary for resource-limited countries.

Authors:  Praveen Khilnani; Sunit Singhi; Rakesh Lodha; Indumathi Santhanam; Anil Sachdev; Krishan Chugh; M Jaishree; Suchitra Ranjit; Bala Ramachandran; Uma Ali; Soonu Udani; Rajiv Uttam; Satish Deopujari
Journal:  Indian J Crit Care Med       Date:  2010-01

8.  Serum free cortisol index, free cortisol, and total cortisol in critically ill children.

Authors:  Preamrudee Poomthavorn; Rojjanee Lertbunrian; Aroonwan Preutthipan; Arporn Sriphrapradang; Patcharin Khlairit; Pat Mahachoklertwattana
Journal:  Intensive Care Med       Date:  2009-04-08       Impact factor: 17.440

9.  ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation.

Authors:  Cláudio F de Oliveira; Débora S F de Oliveira; Adriana F C Gottschald; Juliana D G Moura; Graziela A Costa; Andréa C Ventura; José Carlos Fernandes; Flávio A C Vaz; Joseph A Carcillo; Emanuel P Rivers; Eduardo J Troster
Journal:  Intensive Care Med       Date:  2008-03-28       Impact factor: 17.440

10.  GAP between knowledge and skills for the implementation of the ACCM/PALS septic shock guidelines in India: is the bridge too far?

Authors:  Indumathy Santhanam; Niranjan Kissoon; S R Kamath; Suchitra Ranjit; Jayanthi Ramesh; Janani Shankar
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.